NUZE - VIR HEPA and POLA among pre market gainers

Cumberland Pharmaceuticals CPIX +90% on FDA label expansion for pain therapy Pioneer Power Solutions (NASDAQ:PPSI) +66%. First Wave BioPharma (NASDAQ:FWBI) +53% announces independent data monitoring committee provides positive interim safety assessment for part 2 COVID-19 RESERVOIR clinical trial of Niclosamide for the treatment of gastrointestinal infections ERYTECH Pharma (NASDAQ:ERYP) +41% secures US patent directed to sequential use of Methioninase & Asparaginase against solid tumors ImmunoGen IMGN +38% on positive mirvetuximab data in ovarian cancer Guardforce AI (NASDAQ:GFAI) +29% wins five year bid to operate consolidated cash center in Hadyai, Thailand Allied Healthcare Products AHPI +15% amid social media chatter Vir Biotechnology (NASDAQ:VIR) +15%. GBS (NASDAQ:GBS) +15% announces plans for clinical SARS-CoV-2 antibody trials following validation study Molecular Partners MOLN +13% confirms retained activity of ensovibep on positions mutated in Omicron Polar Power (NASDAQ:POLA) +12%. Heat Biologics HTBX +11% unveils RapidVax vaccine platform targeting emerging biological threats NuZee (NASDAQ:NUZE) +11%. Context Therapeutics (NASDAQ:CNTX) +11%. Athersys ATHX +11% on publication of cell therapy study results against respiratory disorder

For further details see:

VIR, HEPA and POLA among pre market gainers